Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$45.01

-0.95 (-2.07%)

10:15
07/11/19
07/11
10:15
07/11/19
10:15

Bristol Myers Squibb put volume heavy and directionally bearish

Bearish flow noted in Bristol Myers Squibb with 10,710 puts trading, or 3x expected. Most active are Jul-19 44.5 puts and Jul-19 46 calls, with total volume in those strikes near 7,000 contracts. The Put/Call Ratio is 1.89, while ATM IV is up nearly 2 points on the day. Earnings are expected on July 25th.

  • 25

    Jul

  • 16

    Sep

BMY Bristol-Myers
$45.01

-0.95 (-2.07%)

07/11/19
RAJA
07/11/19
NO CHANGE
RAJA
Death of drug rebate rule a win for PBMs and distributors, says Raymond James
After multiple media outlets, including Politico, reported that the Trump Administration has decided to withdraw the drug rebate rule, Raymond James analyst Chris Meekins called the news "a win" for pharmacy benefit managers and drug distributors and "a slight negative" for the pharmaceutical makers. The cost of the proposal to the government was ultimately too high with little guarantee that list prices would go down, said Meekins. However, President Trump hinted something "major" on drug pricing was coming over the next week during his kidney care speech and the analyst thinks the President is planning to move forward with an executive order on pricing. Publicly traded pharmaceutical distributors include McKesson (MCK), Cardinal Health (CAH), Amerisource (ABC) and Patterson (PDCO). Owners of pharmacy benefit managers include CVS Health (CVS), UnitedHealth (UNH), Anthem (ANTM) and Cigna (CI). Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06/25/19
WBLR
06/25/19
NO CHANGE
WBLR
Outperform
Bristol-Myers sentiment suffered 'double hit' yesterday, says William Blair
William Blair analyst Matt Phipps said Bristol-Myers (BMY) suffered a "double hit to sentiment" yesterday with the news of both the CheckMate-459 trial failure in first-line hepatocellular carcinoma and delay of the closing of its Celgene (CELG) deal due to the required Otezla divestiture. He had previously modeled Opdivo sales in the front-line setting of over $1B and Otezla sales growing to $3B before loss of exclusivity in 2028 and decreased his out-year EPS estimates by over $1.00 due to yesterday's news. However, although near-term sentiment is dampened, he still sees a long-term opportunity, said Phipps, who keeps an Outperform rating on Bristol-Myers shares.
06/24/19
CANT
06/24/19
NO CHANGE
Target $100
CANT
Neutral
Celgene pushback surprising, but deal should still close, says Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young said she was surprised by the FTC pushback around Otezla and its overlap in psoriasis related to Celgene's (CELG) oral TYK2 program BMS-986165 in psoriasis given that the latter has not yet reported Phase 3 data. After speaking to Bristol-Myers (BMY), Young said management was also disappointed in this FTC decision, which they said was not related to current asset Orencia marketed for rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. Though timelines are delayed, she still sees "a high likelihood" that the deal closes, but potentially 4-6 months behind schedule. Young, who sees many players in Inflammation & Immunology that could leverage oral Otezla with their existing salesforce, added that Bristol may not lose much in value from this divestiture if the process is competitive. She keeps a Neutral rating and $100 price target on Celgene shares.
05/30/19
GUGG
05/30/19
NO CHANGE
GUGG
Buy
Array BioPharma could be seen as target after 'de-risking' data, says Guggenheim
Guggenheim analyst Michael Schmidt said Array Biopharma (ARRY) may be perceived by investors as a theoretical acquisition target following the disclosure of Phase 3 interim results of Braftovi/Mektovi in BRAF+ colorectal cancer, which he views as positive and a "de-risking event." 67% of announced acquisitions in oncology with a comparable market cap to Array had what he would consider major pipeline de-risking events in the 6 months prior to their deal announcements, Schmidt tells investors. Merck (MRK) and Pfizer (PFE) "seem to have most bandwidth for a deal," said Schmidt, who added that those two along with Bristol-Myers (BMY), AstraZeneca (AZN) and Roche (RHHBY) scored highest as possible large cap theoretical acquirers of Array in his analysis. Schmidt raised his price target on Array Biopharma shares to $38 from $37, though his analysis suggests a potential $40-$50 acquisition price if the company were to be bought.

TODAY'S FREE FLY STORIES

TELL

Tellurian

$6.99

0.32 (4.80%)

13:05
07/18/19
07/18
13:05
07/18/19
13:05
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:57
07/18/19
07/18
12:57
07/18/19
12:57
Conference/Events
Stephens architecture analysts to hold analyst/industry conference call nosymbol »

Analysts hold an…

EMR

Emerson

$64.26

-0.4 (-0.62%)

12:55
07/18/19
07/18
12:55
07/18/19
12:55
Options
Emerson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

  • 22

    Aug

  • 06

    Sep

12:45
07/18/19
07/18
12:45
07/18/19
12:45
General news
Treasury $14 B 10-year TIPS preview: the auction outlook is mixed. »

Treasury $14 B 10-year…

FB

Facebook

$200.15

-1.82 (-0.90%)

12:43
07/18/19
07/18
12:43
07/18/19
12:43
Periodicals
Instagram hiding 'likes' in more countries to ease pressure, Gadgets says »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

DHR

Danaher

$141.79

2.19 (1.57%)

12:40
07/18/19
07/18
12:40
07/18/19
12:40
Recommendations
Danaher analyst commentary at Piper Jaffray »

Danaher price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 07

    Nov

AXP

American Express

$128.02

0.975 (0.77%)

, V

Visa

$179.16

(0.00%)

12:39
07/18/19
07/18
12:39
07/18/19
12:39
Earnings
Fly Intel: What to watch in credit card space earnings reports »

American Express (AXP),…

AXP

American Express

$128.02

0.975 (0.77%)

V

Visa

$179.16

(0.00%)

MA

MasterCard

$275.83

0.49 (0.18%)

UBER

Uber

$43.74

0.12 (0.28%)

LYFT

Lyft

$65.51

0.35 (0.54%)

WU

Western Union

$20.42

0.02 (0.10%)

BBVA

Banco Bilbao

$5.42

-0.055 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 23

    Jul

  • 30

    Jul

  • 01

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Oct

  • 13

    Nov

BUD

AB InBev

$88.73

0.31 (0.35%)

, KKR

KKR

$25.38

-0.08 (-0.31%)

12:36
07/18/19
07/18
12:36
07/18/19
12:36
Periodicals
AB InBev weighs asset sales after calling off Asian IPO, WSJ reports »

Anheuser-Busch InBev…

BUD

AB InBev

$88.73

0.31 (0.35%)

KKR

KKR

$25.38

-0.08 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

ESV

Ensco Rowan

$7.74

-0.16 (-2.03%)

12:35
07/18/19
07/18
12:35
07/18/19
12:35
Options
Ensco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 27

    Aug

CHS

Chico's

$3.29

-0.13 (-3.80%)

12:34
07/18/19
07/18
12:34
07/18/19
12:34
Hot Stocks
Chico's FAS initiates Fort Myers lockdown after call over active shooter threat »

Chico's FAS issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPE

Callon Petroleum

$4.87

-0.35 (-6.71%)

12:33
07/18/19
07/18
12:33
07/18/19
12:33
Conference/Events
Callon Petroleum management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

  • 27

    Aug

BUD

AB InBev

$88.64

0.22 (0.25%)

12:29
07/18/19
07/18
12:29
07/18/19
12:29
Hot Stocks
Breaking Hot Stocks news story on AB InBev »

AB InBev up 1% to $89.30…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

BUD

AB InBev

$88.64

0.22 (0.25%)

12:29
07/18/19
07/18
12:29
07/18/19
12:29
Periodicals
Breaking Periodicals news story on AB InBev »

AB InBev exploring asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UAL

United Continental

$94.94

0.11 (0.12%)

, BA

Boeing

$363.48

-5.97 (-1.62%)

12:28
07/18/19
07/18
12:28
07/18/19
12:28
Hot Stocks
United to resume service between New York/Newark and Delhi and Mumbai »

United Airlines (UAL)…

UAL

United Continental

$94.94

0.11 (0.12%)

BA

Boeing

$363.48

-5.97 (-1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

12:25
07/18/19
07/18
12:25
07/18/19
12:25
Conference/Events
William Blair enterprise & cloud infrastructure analyst to hold a group luncheon »

Enterprise & Cloud…

BA

Boeing

$363.39

-6.06 (-1.64%)

12:24
07/18/19
07/18
12:24
07/18/19
12:24
Periodicals
Some Boeing planes may be prone to cell phone interference, Bloomberg says »

According to a story from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

MBUU

Malibu Boats

$35.98

-0.7 (-1.91%)

12:23
07/18/19
07/18
12:23
07/18/19
12:23
Hot Stocks
Malibu Boats licenses wakesurfing patent portfolio to Sanger Boats »

Malibu Boats announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBPH

Spring Bank Pharmaceuticals

$5.59

0.48 (9.39%)

, ARWR

Arrowhead

$29.53

0.99 (3.47%)

12:22
07/18/19
07/18
12:22
07/18/19
12:22
Recommendations
Spring Bank Pharmaceuticals, Arrowhead, Johnson & Johnson, Gilead analyst commentary at Piper Jaffray »

Spring Bank research…

SBPH

Spring Bank Pharmaceuticals

$5.59

0.48 (9.39%)

ARWR

Arrowhead

$29.53

0.99 (3.47%)

JNJ

Johnson & Johnson

$131.79

-0.03 (-0.02%)

GILD

Gilead

$66.86

-0.05 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

  • 16

    Sep

  • 15

    Oct

AKZOY

AkzoNobel

$0.00

(0.00%)

, PPG

PPG

$116.71

0.105 (0.09%)

12:19
07/18/19
07/18
12:19
07/18/19
12:19
Periodicals
Axalta has drawn interest from suitors, wants deal by fall, Bloomberg reports »

Axalta Coating Systems…

AKZOY

AkzoNobel

$0.00

(0.00%)

PPG

PPG

$116.71

0.105 (0.09%)

AXTA

Axalta Coating

$30.40

0.18 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 25

    Jul

  • 05

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
07/18/19
07/18
12:17
07/18/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
07/18/19
07/18
12:16
07/18/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPG

PPG

$116.73

0.125 (0.11%)

, AKZOY

AkzoNobel

$0.00

(0.00%)

12:15
07/18/19
07/18
12:15
07/18/19
12:15
Periodicals
Breaking Periodicals news story on PPG, AkzoNobel, Axalta Coating »

Axalta has drawn interest…

PPG

PPG

$116.73

0.125 (0.11%)

AKZOY

AkzoNobel

$0.00

(0.00%)

AXTA

Axalta Coating

$30.40

0.18 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 25

    Jul

  • 05

    Aug

S

Sprint

$6.84

-0.26 (-3.66%)

12:15
07/18/19
07/18
12:15
07/18/19
12:15
Options
Sprint put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

NFLX

Netflix

$322.14

-40.36 (-11.13%)

, IBM

IBM

$148.50

5.43 (3.80%)

12:13
07/18/19
07/18
12:13
07/18/19
12:13
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been weaker…

NFLX

Netflix

$322.14

-40.36 (-11.13%)

IBM

IBM

$148.50

5.43 (3.80%)

UNH

UnitedHealth

$258.65

-8.06 (-3.02%)

PM

Philip Morris

$87.41

6.35 (7.83%)

EBAY

eBay

$39.92

0.885 (2.27%)

UNP

Union Pacific

$171.40

7.35 (4.48%)

ADTN

Adtran

$12.28

-3.56 (-22.47%)

LLNW

Limelight Networks

$2.54

-0.23 (-8.30%)

HON

Honeywell

$171.70

2.89 (1.71%)

ALLY

Ally Financial

$33.01

1.57 (4.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 06

    Aug

  • 06

    Aug

  • 26

    Aug

HON

Honeywell

$171.68

2.87 (1.70%)

, BAESY

BAE Systems

$0.00

(0.00%)

12:08
07/18/19
07/18
12:08
07/18/19
12:08
Hot Stocks
BAE Systems names Travis Garriss as CIO, Alice Eldridge as general counsel »

BAE Systems (BAESY)…

HON

Honeywell

$171.68

2.87 (1.70%)

BAESY

BAE Systems

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.